CBDX Stock Overview

Focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. More details

CBDX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($26K)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Curative Biosciences, Inc. Competitors

Lucy Scientific Discovery

OTCPK:LSDI.F

US$882.0

Veritas Farms

OTCPK:VFRM

US$163.9k

Ampio Pharmaceuticals

OTCPK:AMPE

US$97.8k

Altamira Therapeutics

OTCPK:CYTO.F

US$546.3k

Price History & Performance

Summary of share price highs, lows and changes for Curative Biosciences
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0015
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-66.67%
5 Year Change	-99.93%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CBDX	US Pharmaceuticals	US Market
7D	0%	0.4%	-2.1%
1Y	n/a	2.2%	21.3%

Return vs Industry: Insufficient data to determine how CBDX performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CBDX performed against the US Market.

Price Volatility

Is CBDX's price volatile compared to industry and market?
CBDX volatility
CBDX Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: CBDX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CBDX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Richard Damion	curativebio.com

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017.

Curative Biosciences, Inc. Fundamentals Summary

How do Curative Biosciences's earnings and revenue compare to its market cap?
CBDX fundamental statistics
Market cap	US$25.79k
Earnings (TTM)	-US$518.10k
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is CBDX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBDX income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$518.10k
Earnings	-US$518.10k

Last Reported Earnings

Mar 31, 2018

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CBDX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 06:17
End of Day Share Price	2024/12/23 00:00
Earnings	2018/03/31
Annual Earnings	2017/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Curative Biosciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution